CASTLE BIOSCIENCES, INC.
Income Statement
| Line Item | FY2018 |
|---|---|
| Revenue | $22.8M |
| Cost of Revenue | $5.3M |
| Gross Profit | $17.5M |
| Gross Margin | 76.8% |
| Operating Expenses | |
| Research & Development | $4.9M |
| SG&A Expense | $16.5M |
| Operating Income | $-3.8M |
| Operating Margin | -16.8% |
| Interest Expense | $2.3M |
| Pretax Income | — |
| Income Tax Expense | $9.0K |
| Net Income | $-6.4M |
| Net Margin | -27.9% |
| EPS (Basic) | $-0.53 |
| EPS (Diluted) | $-0.53 |
| Shares Outstanding (Basic) | 19.1M |
| Shares Outstanding (Diluted) | 19.1M |
| Dividends Per Share | $0.00 |